Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)

China · Delayed Price · Currency is CNY

5.71

-0.01 (-0.17%)

Sep 30, 2026, 3:00 PM CST

Market Cap	2.28B -35.0%
Revenue (ttm)	634.04M -38.6%
Net Income	-403.17M
EPS	-0.84
Shares Out	400.11M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	809,800
Open	5.72
Previous Close	5.72
Day's Range	5.67 - 5.76
52-Week Range	5.15 - 10.37
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2026

About SHA:605199

Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of digestive system, respiratory system, anti- infective, anti-virus and other fields in China. It offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products. The company was founded in 2005 and is based in Haikou, China. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2005

Employees 2,103

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 605199

Full Company Profile

Financial Performance

In 2025, SHA:605199's revenue was 900.84 million, a decrease of -36.27% compared to the previous year's 1.41 billion. Losses were -287.37 million, 4.71% more than in 2024.

Financial Statements